Are IL-23 blockers as effective as TNF and IL-17 blockers at preventing the progression of PsA?

Featuring Brad Glick, DO, MPH | Board of Directors, American Academy of Dermatology (AAD); Program Director, Dermatology Residency, Larkin Health System, Palm Springs Campus; Assistant Clinical Professor of Dermatology, Herbert Wertheim College of Medicine, Miami, FL | Published July 03, 2023